PT Merck Tbk (MERK.JK)
IDR 3580.0
(0.85%)
IDR 3580.0
(0.85%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 397.86 IDR | -0.89% |
| 2022 | 401.42 IDR | 36.59% |
| 2021 | 293.89 IDR | 83.11% |
| 2020 | 160.50 IDR | -8.12% |
| 2019 | 174.68 IDR | -93.27% |
| 2018 | 2596.71 IDR | 703.93% |
| 2017 | 323.00 IDR | -5.83% |
| 2016 | 343.00 IDR | -86.07% |
| 2015 | 2463.00 IDR | 505.76% |
| 2014 | 406.60 IDR | 3.83% |
| 2013 | 391.60 IDR | 62.73% |
| 2012 | 240.65 IDR | -53.36% |
| 2011 | 516.00 IDR | 94.61% |
| 2010 | 265.15 IDR | -19.03% |
| 2009 | 327.45 IDR | 48.74% |
| 2008 | 220.15 IDR | 10.21% |
| 2007 | 199.75 IDR | 3.42% |
| 2006 | 193.15 IDR | 49.96% |
| 2005 | 128.80 IDR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q3 | 65.21 IDR | 24.09% |
| 2024 Q2 | 52.55 IDR | -0.85% |
| 2024 Q1 | 53.00 IDR | -50.38% |
| 2023 FY | - IDR | -0.89% |
| 2023 Q4 | 106.81 IDR | 22.62% |
| 2023 Q3 | 87.11 IDR | -13.38% |
| 2023 Q2 | 100.57 IDR | -2.71% |
| 2023 Q1 | 103.37 IDR | 53.89% |
| 2022 Q3 | 58.81 IDR | -56.66% |
| 2022 Q2 | 135.69 IDR | -2.91% |
| 2022 Q1 | 139.76 IDR | 351.42% |
| 2022 FY | - IDR | 36.59% |
| 2022 Q4 | 67.17 IDR | 14.22% |
| 2021 FY | - IDR | 83.11% |
| 2021 Q1 | 119.00 IDR | 216.66% |
| 2021 Q2 | 63.01 IDR | -47.05% |
| 2021 Q3 | 80.91 IDR | 28.41% |
| 2021 Q4 | 30.96 IDR | -61.74% |
| 2020 FY | - IDR | -8.12% |
| 2020 Q2 | -6.41 IDR | -108.22% |
| 2020 Q4 | 37.58 IDR | -26.64% |
| 2020 Q1 | 78.00 IDR | -42.89% |
| 2020 Q3 | 51.23 IDR | 899.22% |
| 2019 FY | - IDR | -93.27% |
| 2019 Q1 | 26.00 IDR | -98.86% |
| 2019 Q2 | -12.13 IDR | -146.65% |
| 2019 Q3 | 24.44 IDR | 301.48% |
| 2019 Q4 | 136.58 IDR | 458.84% |
| 2018 Q3 | 107.29 IDR | 26.16% |
| 2018 Q2 | 85.04 IDR | -27.32% |
| 2018 FY | - IDR | 703.93% |
| 2018 Q1 | 117.00 IDR | 933.93% |
| 2018 Q4 | 2287.84 IDR | 2032.39% |
| 2017 Q2 | 77.82 IDR | -47.06% |
| 2017 FY | - IDR | -5.83% |
| 2017 Q4 | -14.03 IDR | -112.49% |
| 2017 Q3 | 112.32 IDR | 44.33% |
| 2017 Q1 | 147.00 IDR | 131.93% |
| 2016 FY | - IDR | -86.07% |
| 2016 Q1 | 135.00 IDR | 186.62% |
| 2016 Q2 | 82.15 IDR | -39.15% |
| 2016 Q3 | 63.48 IDR | -22.73% |
| 2016 Q4 | 63.38 IDR | -0.16% |
| 2015 Q1 | 2243.00 IDR | 2453.22% |
| 2015 Q2 | 88.61 IDR | -96.05% |
| 2015 Q3 | 70.65 IDR | -20.27% |
| 2015 Q4 | 47.10 IDR | -33.33% |
| 2015 FY | - IDR | 505.76% |
| 2014 FY | - IDR | 3.83% |
| 2014 Q1 | 138.00 IDR | 199.09% |
| 2014 Q2 | 89.15 IDR | -35.4% |
| 2014 Q4 | 87.85 IDR | -2.44% |
| 2014 Q3 | 90.05 IDR | 1.01% |
| 2013 FY | - IDR | 62.73% |
| 2013 Q4 | 46.14 IDR | -42.25% |
| 2013 Q3 | 79.90 IDR | -3.56% |
| 2013 Q2 | 82.85 IDR | -54.65% |
| 2013 Q1 | 182.70 IDR | 5831.82% |
| 2012 Q2 | 92.55 IDR | 6.56% |
| 2012 Q4 | 3.08 IDR | -94.7% |
| 2012 FY | - IDR | -53.36% |
| 2012 Q1 | 86.85 IDR | -62.91% |
| 2012 Q3 | 58.15 IDR | -37.17% |
| 2011 FY | - IDR | 94.61% |
| 2011 Q3 | 78.60 IDR | -22.18% |
| 2011 Q2 | 101.00 IDR | -1.22% |
| 2011 Q1 | 102.25 IDR | 68.37% |
| 2011 Q4 | 234.13 IDR | 197.88% |
| 2010 Q4 | 60.73 IDR | 0.0% |
| 2010 FY | - IDR | -19.03% |
| 2010 Q1 | 89.00 IDR | 23.49% |
| 2009 FY | - IDR | 48.74% |
| 2009 Q4 | 72.07 IDR | 0.0% |
| 2009 Q1 | 89.90 IDR | 0.0% |
| 2008 FY | - IDR | 10.21% |
| 2007 FY | - IDR | 3.42% |
| 2006 FY | - IDR | 49.96% |
| 2005 FY | - IDR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| PT Darya-Varia Laboratoria Tbk | 130.66 IDR | -204.5% |
| PT Phapros, Tbk | 7.09 IDR | -5511.566% |
| PT Pyridam Farma Tbk | -34.20 IDR | 1263.333% |
| PT Industri Jamu dan Farmasi Sido Muncul Tbk | 31.69 IDR | -1155.475% |
| PT Tempo Scan Pacific Tbk | 261.08 IDR | -52.39% |